Complanatuside ameliorates renal injury and fibrosis in chronic kidney disease by inhibiting tubular cell apoptosis via activation of KLK1/BDKRB2

The Journal of Nutritional Biochemistry · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles